Debido a los beneficios en el control glucmico y en la salud cardiovascular, estos frmacos pueden ser implementados en monoterapia de primera lnea cuando est contraindicada la metformina, en combinacin con otros agentes hipoglucemiantes orales, excepto los IDPP-4, incluso pudindose combinar con insulina..Por otra parte, los IDPP-4, como su nombre lo indica, actan inactivando la enzima proteoltica DPP-4, que es responsable de la degradacin del GLP-1 y el GIP, lo que permite reducir la velocidad de degradacin
Jeli pacjent potrzebuje omwienia dokumentacji lub kontynuacji leczenia, moe skorzysta z konsultacji online na e-medycy.pl
*Correspondence: Bing Zheng [email protected] Gong [email protected] This article was submitted to Inflammation, a section of the journal Frontiers in Immunology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Table of Contents Why Retatrutide Causes Diarrhoea in Some People Retatrutide causes diarrhoea through multifactorial mechanisms likely involving delayed gastric emptying, altered intestinal fluid secretion, and CNS effects on gut function, consistent with the broader GLP-1 receptor agonist drug class
Media was removed after 72 h of incubation and cells were washed thrice with DPBS